CELERITY 2D 85Recalls & reported problems
BIOTRONIK SE & Co. KG · Class 3 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 04035479143268), received between Dec 11, 2019 and Jul 22, 2020 — classified as 1 death, 1 malfunction.
The most frequently reported specific device problem is “High Capture Threshold” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- High Capture Threshold1
Patient problems
- Death1
- No Known Impact Or Consequence To Patient1
- Unspecified Infection1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
DeathJul 22, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
LIVANOVA/MICROPORT PROVIDED THE FOLLOWING INFORMATION: ON (B)(6) 2017, PATIENT PRESENTED 2 WEEKS STATUS-POST RIGHT TOE/FOOT RESECTION COMPLAINING OF RIGHT FOOT PAIN, ERYTHEMA AND SWELLING. FOOT CULTURE (B)(6) FOR (B)(6). TREATMENT PLAN PER INFECTIOUS DISEASE. ON (B)(6) 2017, PATIENT PRESENTED TO EMERGENCY DEPARTMENT WITH WORSENING SHORTNESS OF BREATH, LOWER EXTREMITY EDEMA AND ASCITES. BLOOD CULTURES (B)(6) FOR (B)(6) ON (B)(6) 2017, AND (B)(6) 2017. TREATED WITH INTRAVENOUS DAPTOMYCIN. RIGHT FOOT NOW CONSISTENT WITH OSTEOMYELITIS. ON (B)(6) 2017, DEVICE SITE WAS ERYTHEMOUS. DEVICE AND THREE LEADS WERE EXTRACTED ON (B)(6) 2017. TISSUE SHOWED EVIDENCE OF INFECTION (B)(6) FOR (B)(6). ON (B)(6) 2018, FOLLOWING SIX WEEKS OF OUTPATIENT DAPTOMYCIN, BLOOD CULTURE FROM (B)(6) 2018 WAS (B)(6) FOR (B)(6). SWITCHED TO INTRAVENOUS VANCOMYCIN. PATIENT NEVER FULLY RECOVERED FROM SYSTEMIC (B)(6) INFECTION AND EVENTUALLY PASSED AWAY.
Patient problems: Death; Unspecified Infection
MAUDE report 10311375 ↗MalfunctionDec 11, 2019High Capture Threshold; High Capture Threshold
THIS LEAD WAS CAPPED DUE TO VERY HIGH LV THRESHOLDS CAUSING DEVICE BATTERY DEPLETION.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9452130 ↗
Other Drug eluting permanent left ventricular (lv) pacemaker electrode devices
- Attain Stability™ Quad MRI SureScan™ 479888Medtronic, Inc. · Drug eluting permanent left ventricular (lv) pacemaker electrode28 deaths2,213 reports
- Attain Performa™ Straight MRI SureScan™ 439888Medtronic, Inc. · Drug eluting permanent left ventricular (lv) pacemaker electrode26 deaths1,595 reports
- Sentus ProMRI OTW QP L-85/49 408719BIOTRONIK SE & Co. KG · Drug eluting permanent left ventricular (lv) pacemaker electrode7 deaths1,385 reports
- Quartet™ 1457Q-86St. Jude Medical, Inc. · Drug eluting permanent left ventricular (lv) pacemaker electrode21 deaths1,061 reports
- Quickflex™ 1258TSt. Jude Medical, Inc. · Drug eluting permanent left ventricular (lv) pacemaker electrode26 deaths996 reports
- ATTAIN® BIPOLAR OTW 419488Medtronic, Inc. · Drug eluting permanent left ventricular (lv) pacemaker electrode15 deaths730 reports
- Attain Ability® Plus 429688Medtronic, Inc. · Drug eluting permanent left ventricular (lv) pacemaker electrode11 deaths529 reports
- Sentus ProMRI OTW QP S-85/49 406082BIOTRONIK SE & Co. KG · Drug eluting permanent left ventricular (lv) pacemaker electrode1 death511 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page